bpc 157 drug Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides BPC 157 Banned: Key Facts

Caution is advised in patients with kidney disease, liver disorders, or known hypersensitivity to any component

Neurochemical Research .Read source (2022)

The major downside to injectables is that these IV therapy treatments can be expensive ($200-500+ per session) and require clinical visits that can take hours, not to mention needles, making them inaccessible for most people

169 While socially and cognitively stimulating activities appear to reduce risk, it is also possible that undetected cognitive impairment decreases one's interest in and ability to participate in activities involving social and cognitive skills